Chebulagic acid suppresses gastric cancer by inhibiting the AURKA/β-catenin/Wnt pathway
Jing Zhao(Jiangnan University), Jieer Ying(Zhejiang Cancer Hospital)
Cited by 10
Related Papers
Zanidatamab for HER2-amplified, unresectable, locally advanced or metastatic biliary tract cancer (HERIZON-BTC-01): a multicentre, single-arm, phase 2b study
|The Lancet Oncology|2023|243